{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:35:59Z","timestamp":1789097759517,"version":"build-2803163510"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T00:00:00Z","timestamp":1459123200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s00403-016-1641-z","type":"journal-article","created":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T11:21:52Z","timestamp":1459164112000},"page":"277-281","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Hashimoto\u2019s thyroiditis could be secondary to vitiligo: the possibility of antigen crossover and oxidative stress between the two diseases"],"prefix":"10.1007","volume":"308","author":[{"given":"Qingli","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixing","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,28]]},"reference":[{"key":"1641_CR1","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/bjd.13286","volume":"171","author":"R Colucci","year":"2014","unstructured":"Colucci R, Lotti F, Dragoni F, Arunachalam M, Lotti T, Benvenga S, Moretti S (2014) High prevalence of circulating autoantibodies against thyroid hormones in vitiligo and correlation with clinical and historical parameters of patients. Br J Dermatol 171:786\u2013798","journal-title":"Br J Dermatol"},{"key":"1641_CR2","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1461::AID-CNCR3>3.0.CO;2-E","volume":"79","author":"P Fishman","year":"1997","unstructured":"Fishman P, Merimski O, Baharav E, Shoenfeld Y (1997) Autoantibodies to tyrosinase: the bridge between melanoma and vitiligo. Cancer 79:1461\u20131464","journal-title":"Cancer"},{"key":"1641_CR3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000081479","volume":"210","author":"P Iacovelli","year":"2005","unstructured":"Iacovelli P, Sinagra JL, Vidolin AP, Marenda S, Capitanio B, Leone G, Picardo M (2005) Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo. Dermatology 210:26\u201330","journal-title":"Dermatology"},{"key":"1641_CR4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2249.1997.4781381.x","volume":"109","author":"EH Kemp","year":"1997","unstructured":"Kemp EH, Gawkrodger DJ, Watson PF, Weetman AP (1997) Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2). Clin Exp Immunol 109:495\u2013500","journal-title":"Clin Exp Immunol"},{"key":"1641_CR5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2249.1998.00746.x","volume":"114","author":"EH Kemp","year":"1998","unstructured":"Kemp EH, Gawkrodger DJ, Watson PF, Weetman AP (1998) Autoantibodies to human melanocyte-specific protein pmel17 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA). Clin Exp Immunol 114:333\u2013338","journal-title":"Clin Exp Immunol"},{"key":"1641_CR6","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1046\/j.1365-2133.1998.02503.x","volume":"39","author":"EH Kemp","year":"1998","unstructured":"Kemp EH, Waterman EA, Gawkrodger DJ, Watson PF, Weetman AP (1998) Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay. Br J Dermatol 39:798\u2013805","journal-title":"Br J Dermatol"},{"key":"1641_CR7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12011-010-8625-1","volume":"138","author":"S Lassoued","year":"2010","unstructured":"Lassoued S, Mseddi M, Mnif F, Abid M, Guermazi F, Masmoudi H, El Feki A, Attia H (2010) A comparative study of the oxidative profile in Graves\u2019 disease, Hashimoto\u2019s thyroiditis, and papillary thyroid cancer. Biol Trace Elem Res 138:107\u2013115","journal-title":"Biol Trace Elem Res"},{"key":"1641_CR8","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1600-0749.2007.00408.x","volume":"20","author":"MR Namazi","year":"2007","unstructured":"Namazi MR (2007) Neurogenic dysregulation, oxidative stress, autoimmunity, and melanocytorrhagy in vitiligo: could they be interconnected? Pigment Cell Res 20:360\u2013363","journal-title":"Pigment Cell Res"},{"key":"1641_CR9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2012.11197.x","volume":"168","author":"A Taieb","year":"2013","unstructured":"Taieb A, Alomar A, B\u00f6hm M, Dell\u2019anna ML, De Pase A, Eleftheriadou V, Ezzedine K, Gauthier Y, Gawkrodger DJ, Jouary T, Leone G, Moretti S, Nieuweboer-Krobotova L, Olsson MJ, Parsad D, Passeron T, Tanew A, van der Veen W, van Geel N, Whitton M, Wolkerstorfer A, Picardo M, Vitiligo European Task Force (VETF), European Academy of Dermatology and Venereology (EADV), Union Europe\u00b4enne des Me\u00b4decins Spe\u00b4cialistes (UEMS) (2013) Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol 168:5\u201319","journal-title":"Br J Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-016-1641-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-016-1641-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-016-1641-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:39:59Z","timestamp":1559065199000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-016-1641-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,28]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["1641"],"URL":"https:\/\/doi.org\/10.1007\/s00403-016-1641-z","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,28]]}}}